The Lead Episode 146: Heart Rhythm 2026 Late Breaker Coverage: A Discussion of LEAP2: A First-In-Human Study of a Chronically-Implanted Novel Leadless Pacemaker for Conduction System Pacing-The Lead Episode 146 Speaker Information

The Lead Episode 146 Speaker Information

Pdf Summary

This document is a title slide for a Heart Rhythm 2026 Late Breaker discussion on LEAP2, a first-in-human study of a chronically implanted novel leadless pacemaker for conduction system pacing. The session is hosted by Christopher C. Cheung, MD, MPH, FHRS, from Sunnybrook HSC, University of Toronto.<br /><br />The slide introduces the event’s contributors: Mihail G. Chelu, MD, PhD, FHRS, from Baylor College of Medicine, and Derek Chew, MD, MS, FHRS, from the University of Calgary. It also lists disclosures for the presenters. Dr. Cheung reports honoraria, speaking, teaching, and consulting relationships with Medtronic, Biotronik, Biosense Webster, Abbott, and Impulse Dynamics USA, along with research support from Abbott, Impulse Dynamics USA, VDI Technologies, PCORI, and NIH/NHLBI. Dr. Chew reports research support from the Canadian Institute of Health Research and the Heart and Stroke Foundation of Canada.<br /><br />Overall, the document serves as introductory and disclosure information for a scientific presentation rather than presenting study findings.

Keywords

Heart Rhythm 2026

LEAP2

late breaker

leadless pacemaker

conduction system pacing

first-in-human study

Christopher C. Cheung

Mihail G. Chelu

Derek Chew

disclosures